Pemafibrate (but not fenofibric acid) upregulated the genes encoding mannose-binding lectin 2 (MBL2), involved in regulation of the innate immune system, inflammation and, possibly, vascular complications in diabetes [46, 47], as well as glutamyl aminopeptidase (ENPEP), involved in regulation of blood pressure [48], in transcriptome analysis [43]. Here, MBL2 is linked to diabetes mellitus.